Business Context and Reporting Period
This Form 8-K is a current report filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on December 8, 2022, covering events occurring on December 5, 2022. The filing addresses corporate governance changes, specifically the appointment of a new Chief Operating Officer and the resignation of a Board member.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on personnel changes and compensatory arrangements.
Material Changes
- Appointment of Chief Operating Officer: The Board appointed Bren Kern, previously the Senior Vice President of Manufacturing and Operations, as Chief Operating Officer, effective January 1, 2023.
- Resignation of Director: Dr. Julia Haller resigned from the Board of Directors, effective December 6, 2022. The resignation was not the result of any disagreement with the Company.
Guidance, Outlook, and Management Commentary
Compensatory Arrangements for Mr. Kern:
- Base Salary: $345,000 annually.
- Cash Bonus: Eligible for up to 30% of base salary.
- Equity: Option to purchase 120,000 shares of common stock.
- Benefits: Participation in senior management benefit plans, including vacation, sick, and holiday pay.
Management Commentary: Mr. Kern brings over 20 years of experience in transitioning companies from R&D to scaled commercial manufacturing, with a background in medical devices and diagnostics. The full Employment Agreement will be filed as an exhibit to the Annual Report on Form 10-K for the year ending December 31, 2022.
Investor Verification Checklist
- Verify the exact terms of the Employment Agreement for Bren Kern in the upcoming Form 10-K filing.
- Confirm the status of the Board of Directors following Dr. Haller's resignation and whether a replacement has been nominated.
- Review the press release (Exhibit 99.1) for additional context on the strategic rationale for the leadership change.